"Pet Negativity"—The New Goal of Cytoreductive Therapy in Hodgkin's Lymphoma?

John W. Sweetenham
2011 Biology of Blood and Marrow Transplantation  
doi:10.1016/j.bbmt.2011.08.006 pmid:21840291 fatcat:cnwsg3h7breybeywa4riswb2yq